Barclays’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-5,600
| Closed | -$312K | – | 7630 |
|
|
2018
Q4 | $312K | Sell |
5,600
-100
| -2% | -$5.43K | ﹤0.01% | 4255 |
|
|
2018
Q3 | $265K | Buy |
5,700
+4,700
| +470% | +$227K | ﹤0.01% | 4771 |
|
|
2018
Q2 | $48K | Sell |
1,000
-6,400
| -86% | -$306K | ﹤0.01% | 5673 |
|
|
2018
Q1 | $320K | Buy |
7,400
+7,300
| +7,300% | +$328K | ﹤0.01% | 4406 |
|
|
2017
Q4 | $4K | Sell |
100
-4,200
| -98% | -$175K | ﹤0.01% | 6718 |
|
|
2017
Q3 | $187K | Sell |
4,300
-7,100
| -62% | -$324K | ﹤0.01% | 4487 |
|
|
2017
Q2 | $545K | Buy |
11,400
+10,800
| +1,800% | +$504K | ﹤0.01% | 3443 |
|
|
2017
Q1 | $25K | Buy |
600
+500
| +500% | +$20.9K | ﹤0.01% | 5716 |
|
|
2016
Q4 | $4K | Sell |
100
-99,900
| -100% | -$4.06M | ﹤0.01% | 6228 |
|
|
2016
Q3 | $5.37M | Buy |
+100,000
| New | +$4.64M | 0.01% | 1234 |
|
Barclays's IMPV Position: Q1 2019 in Review
Barclays sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 145 shares — an estimated $8K sold.
Barclays first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $933K in Q2 2014. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- Barclays reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- Barclays sold 145 Imperva, Inc. shares in Q1 2019, an estimated $8K.
- Barclays first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
- Barclays's Imperva, Inc. position peaked at $933K in Q2 2014.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.